Here, an overview of potential compounds tested for the treatment of Duchenne muscular dystrophy is given. This includes compounds aiming to restore/ replace the missing dystrophin and compounds targeting one or more of the secondary effects (e.g. fibrosis of inflammation) of the absence of dystrophin.